✦ LIBER ✦

A decade of new cancer drugs: good value for money

✍ Scribed by Laschober, Tanja C.; Tormes Eby, Lillian Turner

Book ID: 121633244
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Weight: 111 KB
Volume: 680
Category: Article
ISSN: 1173-5503
DOI: 10.1007/s40274-013-0476-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Not a good buy: Value for money of presc

Not a good buy: Value for money of prescription drugs sold on the Internet

✍ Rosella Levaggi; Claudio Marcantoni; Laura Filippucci; Umberto Gelatti 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Practice nurses "good value for money" i

Practice nurses "good value for money" in diabetes management

✍ Cotta, Michael A.; Whitehead, Terence R.; Falsen, Enevold; Moore, Edward; Lawson 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

A new anti-cancer drug in the market: Go

A new anti-cancer drug in the market: Good news for investors or for patients?

✍ Giovanni Apolone; Giovanni Tafuri; Francesco Trotta; Silvio Garattini 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 108 KB

The importance of new companies for drug

The importance of new companies for drug discovery: origins of a decade of new drugs

✍ Kneller, Robert 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

The importance of new companies for drug

The importance of new companies for drug discovery: origins of a decade of new drugs

✍ Kneller, Robert 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 411 KB

The application of pharmacoeconomic mode

The application of pharmacoeconomic modelling to estimate a value-based price for new cancer drugs

✍ George Dranitsaris; Ilse Truter; Martie S. Lubbe; Wayne Cottrell; Biljana Spirov 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB